| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |